For in vitro laboratory research only. Not for human or veterinary consumption.
India Warehouse TICAGRELOR — 90mg per tablet, 112-count pack. P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack. Key warning: Dyspnea: evaluate for cardiac/pulmonary causes but may be drug effect (usually resolves). Avoid strong CYP3A4 inhibitors/inducers. High bleeding risk especially GI. Do NOT use high-dose aspirin with ticagrelor.
P2Y12 antiplatelet agent for acute coronary syndrome (ACS) and post-MI prevention. Faster, more potent, more consistent platelet inhibition than clopidogrel — reduces mortality after heart attack.
How it Works
Direct-acting reversible P2Y12 ADP receptor antagonist — no metabolic activation required unlike clopidogrel. More predictable and potent antiplatelet effect.
Quick Specs
Form
Oral tablets — pre-dosed
Active Ingredient
TICAGRELOR
Dose per Tablet
90MG
Pack Size
112 tablets
Storage
Room temperature (15–25°C), cool dry place
Shelf Life
2–3 years (properly stored)
Common Side Effects
Dyspnea (unique to ticagrelor — usually mild, not cardiac), bleeding, bradyarrhythmia (transient), elevated uric acid.
Safety Warnings
Dyspnea: evaluate for cardiac/pulmonary causes but may be drug effect (usually resolves). Avoid strong CYP3A4 inhibitors/inducers. High bleeding risk especially GI. Do NOT use high-dose aspirin with ticagrelor. International shipping: 7–14 days
Research use only
This material is supplied strictly for in vitro laboratory research. It is not intended for human or veterinary consumption, diagnosis, treatment, or household use.
